Cost effectiveness of pegylated interferon alpha 2b and ribavirin combination in chronic hepatitis C

被引：4
|
作者：
Poynard, T [1 ]
机构：
[1] Grp Hosp Pitie Salpetriere, Serv Hepatogastroenterol, F-75651 Paris, France
来源：
GUT | 2003年 / 52卷 / 10期
关键词：
D O I：
10.1136/gut.52.10.1532
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1532 / 1532
页数：1
相关论文
共 50 条
  • [41] Effectiveness of varied dose of pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
    Midha, V.
    Sood, A.
    Hissar, S. S.
    Sood, N.
    Kumar, M.
    Sarin, S. K.
    PROCEEDINGS OF THE 16TH CONFERENCE OF THE ASIAN PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER, 2006, : 1 - +
  • [42] Pegylated interferon α2a plus ribavirin versus pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Berenguer, J.
    Gonzalez-Garcia, J.
    Lopez-Aldeguer, J.
    Von-Wichmann, M. A.
    Quereda, C.
    Hernando, A.
    Sanz, J.
    Tural, C.
    Ortega, E.
    Mallolas, J.
    Santos, I.
    Miralles, P.
    Montes, M. L.
    Bellon, J. M.
    Esteban, H.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (06) : 1256 - 1263
  • [43] Pegylated interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C genotype
    Hasan, F
    Asker, H
    Al-Khaldi, J
    Siddique, I
    Owaid, SF
    Al-Ajmi, M
    Al-Nakib, B
    HEPATOLOGY, 2003, 38 (04) : 629A - 629A
  • [44] Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
    Aizawa, Nobuhiro
    Enomoto, Hirayuki
    Takashima, Tomoyuki
    Sakai, Yoshiyuki
    Iwata, Kazunari
    Ikeda, Naoto
    Tanaka, Hironori
    Iwata, Yoshinori
    Saito, Masaki
    Imanishi, Hiroyasu
    Iijima, Hiroko
    Nishiguchi, Shuhei
    JOURNAL OF GASTROENTEROLOGY, 2014, 49 (08) : 1253 - 1263
  • [45] From Trials to a Real Hospital Setting: Effectiveness of Pegylated Interferon-α-2b/Ribavirin Combination Therapy for Naïve Chronic Hepatitis C Patients
    Guido Piai
    Elisa Scalice
    Rosaria Focareta
    Fulvia Terracciano
    Francesca Romana de Filippo
    Giovambattista Forte
    Digestive Diseases and Sciences, 2006, 51 : 1619 - 1626
  • [46] Pegylated interferon-alpha 2b monotherapy for haemodialysis patients with chronic hepatitis C
    Annicchiarico, BE
    Siciliano, M
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (01) : 123 - 124
  • [47] Preliminary treatment results of liver transplant recipients with recurrent hepatitis C virus nonresponsive to interferon alpha2B and ribavirin using combination pegylated interferon alpha 2B with ribavirin.
    Neff, GW
    Montalbano, M
    Lee, YM
    Slapak, G
    Safdar, K
    Morrero, R
    Nery, J
    Weppler, D
    Demodina, M
    Schiff, E
    Tzakis, A
    HEPATOLOGY, 2002, 36 (04) : 183A - 183A
  • [48] Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
    Nobuhiro Aizawa
    Hirayuki Enomoto
    Tomoyuki Takashima
    Yoshiyuki Sakai
    Kazunari Iwata
    Naoto Ikeda
    Hironori Tanaka
    Yoshinori Iwata
    Masaki Saito
    Hiroyasu Imanishi
    Hiroko Iijima
    Shuhei Nishiguchi
    Journal of Gastroenterology, 2014, 49 : 1253 - 1263
  • [49] Efficacy and safety of pegylated interferon alpha-2b and ribavirin in chronic hepatitis C in children
    Kups-Rzepecka, Joanna
    Golabek, Violetta
    Kicinski, Przemyslaw
    Wozniakowska-Gesicka, Teresa
    PRZEGLAD GASTROENTEROLOGICZNY, 2010, 5 (06): : 341 - 348
  • [50] Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon α-2b and ribavirin
    Murakami, Yasuko
    Koyabu, Tomoko
    Kawashima, Aiko
    Kakibuchi, Naoko
    Kawakami, Takayo
    Takaguchi, Kouichi
    Kita, Keiji
    Okita, Misako
    JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY, 2007, 53 (03) : 213 - 218
12345